Upregulation of Cyp19a1 and PPAR-γ in ovarian steroidogenic pathway by Ficus religiosa: A potential cure for polycystic ovary syndrome
Autor: | Mohammad Abdulkader Akbarsha, Smilin Bell Aseervatham, Rajamanickam Ramachandran, Shanmugam Achiraman, Udhayaraj Suriyakalaa, Balamuthu Kadalmani, Soundararajan Kamalakkannan, Jayaraman Angayarkanni, Devaraj Sankarganesh, Jaffar Ali Doulathunnisa |
---|---|
Rok vydání: | 2019 |
Předmět: |
Infertility
medicine.medical_specialty 3-Hydroxysteroid Dehydrogenases 17-Hydroxysteroid Dehydrogenases medicine.drug_class Ovary 03 medical and health sciences 0302 clinical medicine Aromatase Internal medicine Drug Discovery medicine Animals Ficus religiosa Rats Wistar Gonadal Steroid Hormones 030304 developmental biology Pharmacology Estrous cycle 0303 health sciences biology Plant Extracts Female infertility medicine.disease biology.organism_classification Ficus Polycystic ovary Up-Regulation PPAR gamma Plant Leaves Disease Models Animal Endocrinology medicine.anatomical_structure Estrogen 030220 oncology & carcinogenesis biology.protein Female Polycystic Ovary Syndrome Signal Transduction |
Zdroj: | Journal of ethnopharmacology. 267 |
ISSN: | 1872-7573 |
Popis: | Ethnopharmacological relevance Quite a few plants are in use to treat female infertility and associated problems. Availing the cues from traditional knowledge, phytochemical studies and ethnopharmacological evidences, the aphrodisiac plant Ficus religiosa (F. religiosa) is widely in use to cure infertility in women. For instance, the juice of leaf and aerial root of F. religiosa is reported to normalize the dysregulated menstrual cycle in women. Besides, it is believed that regular circumambulation of F. religiosa during the early hours of the morning helps women in alleviating infertility which could be attributed to the potential phytovolatiles released from F. religiosa. However, the evidences for therapeutic potential of F. religiosa in treating female infertility are arbitrary and mostly anecdotal. Aim of the study The present study was aimed at examining if extracts of fresh and/or dry leaf of F. religiosa would cure polycystic ovary syndrome (PCOS) in the rat model. Methods Rats were divided into seven groups; control (Group I), PCOS-induced (P.O, Letrozole −1 mg/kg BW for 21 days) and untreated (Group II), PCOS-induced and treated with the leaf extracts of F. religiosa (Groups III–VI), and, PCOS-induced and treated with pioglitazone (Group VII). The estrous intervals, body and organ weights (ovary and uterus), and serum hormones (testosterone, luteinizing hormone [LH], estrogen, and progesterone) were measured, and the expression of Cyp19a1 (aromatase), and Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) were assessed in the experimental rats. The levels of 3β-hydroxysteroid dehydrogenase (3β-HSD), 17β-hydroxysteroid dehydrogenase (17β-HSD), and antioxidants (MDA, GSH, GPx, SOD, and CAT) were also quantified. Besides, the putative volatile compounds in the esterified leaf extracts were identified using Gas Chromatography-Mass Spectrometry (GC-MS). Results Letrozole treatment induced irregular estrous and altered weight of organs and hormonal milieu, which were reverted to normal in leaf extracts-treated PCOS-induced rats. Remarkably, fresh leaf treatment up-regulated Cyp19a1and PPAR-γ and increased the levels of 3β-HSD and 17β-HSD. We found 3-acetoxy-3-hydroxy-propionic acid in fresh and dry leaf extracts, which we attribute to efficacy of the extracts in alleviating PCOS. Conclusion Put together, our findings suggest the leaves of F. religiosa as potential in alleviating PCOS, mainly due to the presence of putative volatile molecules. Further screening of the leaves of F. religiosa is recommended to identify other key molecules and to develop a systematic therapeutic intervention for PCOS. |
Databáze: | OpenAIRE |
Externí odkaz: |